The U.S. has approved the Pfizer-BioNTech vaccine for children aged five to 11. The U.S. Centers for Disease Control and Prevention on Tuesday recommended the shot for broad use in that age group after a panel of outside advisers voted in favor of it.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3